← Insider buys
DCPH

Deciphera Pharmaceuticals, Inc.

EVP and Chief Medical Officer Matthew L Sherman sold $43K of Deciphera Pharmaceuticals, Inc.

Sold$42,905
$15.37Price
2,792Shares
−3%Stake

What DCPH did after the filing

Prices for DCPH after this filing aren't in yet.

Traded Wed, Dec 13. Filed Thu, Dec 14, 11:05 AM ET, during the session. Not investment advice.